Baxter Recalls Potassium Chloride Injection: AttorneyOne Monitors and Keeps Consumers Informed

Share Article

On September 17, the FDA announced that Baxter International Inc. recalls one lot of Potassium Chloride Injection 10mEq per 100mL due to a labeling error on the shipping cartons. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers.

Potassium Chloride Injection, by Baxter, Recalled

Potassium Chloride Injection, by Baxter, Recalled

It is recommended that healthcare professionals carefully review the product label before administering

AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on Potassium Chloride.

The FDA announced on September 17, that Baxter International Inc. recalled one lot of Potassium Chloride Injection 10mEq per 100mL due to a labeling error on the shipping cartons. Potassium Chloride, administered intravenously, is used to treat potassium deficiency.

The reason for the recall is based on a labeling error on the shipping cartons in a single lot where, for this specific lot number of Potassium Chloride Injection 10mEq per 100mL, product code 2B0826 , they may contain units of Gentamicin Sulfate Injection, 80 mg in 100 mL, product code 2B0862. This may pose a potential risk of medication error or delay in therapy in cases where high concentration potassium chloride is required.
The affected lot is Lot # P318220, NDC # 0338-0709-48.

Taking into consideration the latest developments, AttorneyOne.com monitor daily and update the website providing accurate information on all relevant FDA safety alerts. Sean Burke, director of Media Relations at AttorneyOne.com, adds “we are determined to keep an eye on FDA announcements concerning Potassium Chloride and inform the public. For that reason", he continues, "our focus should squarely fall on investigating these safety alerts and getting the word out.”

As the FDA recommends “It is recommended that healthcare professionals carefully review the product label before administering.” And the Agency adds “Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to using this drug product.”

AttorneyOne.com has further information on Potassium Chloride at the website including the latest major drug, food, and medical products law news.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2014/09/prweb12179371.htm

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sean Burke
Attorney One
+1 877-230-7343
Email >
@Attorney_One
Follow >
Visit website